chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Caller stated he may have gotten the "water " not good or not have gotten the full dose.; he may have gotten a bad dose; He said he got the second dose on the 29Jan "felt the heat like alcohol burning"/Second dose burned a little; he may have gotten a bad dose; This is a spontaneous report from a contactable consumer (patient).   An 85-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EL3249), via an unspecified route of administration on 29Jan2021 as 2nd dose, single for COVID-19 immunization. The patient previously received first dose of BNT162B2 for COVID-19 immunisation and experienced sore arm, felt the fire chills and heat, arm pain for a couple days, felt the burning of it going in, little heat and a little chill but the next day he was on the way to being good. The patient medical history included really sick with the flu before getting the vaccine, it was just sick not really an event and was like he got the flu but in 2 hours. The concomitant medications were Advil and Tylenol. One Benadryl will knock him out. He said he gets sick with flu vaccine. On an unspecified date, the patient experienced felt the heat like alcohol burning when injecting but no sore arm nothing else, did feel the burn and it go into his arm but after an hour he left and has had no pain, none in his arm or hurting, nothing. His mind is going to go there and is thinking did he get a bad dose. He may have gotten the water not good or not have gotten the full dose. He wanted to know the proof that he has gotten the vaccine, are there any blood test or any test he could have to see if he got the vaccine. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Flu shot given in left arm on 1/11/06 at 6:15pm.  3hrs later extreme vertigo and dizziness. Unable to function or drive a car.  Today (1/12/06) still very dizzy and nausea.
Left deltoid, red, warm, some swelling.  Mother advised to put warm compress to area.  Mother could not stay to see MD.
Very swollen and red left thigh 18 hours after DTaP given 11/21/02. Returned 11/22/02.
Pt noted lump at injection site with warmth, redness & itching.  No other complaint/problem.  She applied topical Vaseline without relief.  Instructed to use ZYRTEC which she already has, apply cold compresses.  Site circled & instructed to observe, RTC if enlarges or further problem.
Patient received 2nd  dose of the Moderna vaccine 14 days after his 1st dose.  Patient denies any adverse reactions.
This spontaneous report was received from a nurse practitioner refers to a female patient of unknown age. The patient's medical history and concurrent conditions were not reported. On 09-MAY-2015 and on 11-MAY-2015, the patient was vaccinated with the first and second dose of GARDASIL intramuscular (strength, dose, anatomical location, lot # and expiration date were not reported). On 14-SEP-2015, the patient was in the office to receive GARDASIL 9 as the third dose (strength, dose, anatomical location, lot # and expiration date were not reported) (interchange of vaccine products). There was not a product quality complaint involved. At the time of the report, the outcome the event was unknown. The relatedness of the adverse events and suspect therapy was not provided. Additional information has been requested.
Injection site rash, Injection site induration, Injection site reaction. This case was reported by a physician and described the occurrence of an injection site reaction in a male neonate who received hepatitis B vaccine recombinant (Engerix-B). On an unspecified date in July 2004, the patient received the first dose of Engerix-B at birth. The physician reported that, on an unspecified date post-immunization, the infant developed an indurated rash at the injection site. The physician stated, "almost two months later, if the skin is provoked at the site where the vaccine was administered, an indurated rash appears."
This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness in 2 little toes), ABDOMINAL DISCOMFORT (Now is starting to affect her bowels and bladder) and BLADDER DISCOMFORT (Now is starting to affect her bowels and bladder) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012F27A, 039B21A and 007B21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Apr-2021, the patient experienced HYPOAESTHESIA (Numbness in 2 little toes). On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (Now is starting to affect her bowels and bladder) and BLADDER DISCOMFORT (Now is starting to affect her bowels and bladder). At the time of the report, HYPOAESTHESIA (Numbness in 2 little toes) had not resolved and ABDOMINAL DISCOMFORT (Now is starting to affect her bowels and bladder) and BLADDER DISCOMFORT (Now is starting to affect her bowels and bladder) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: no diagnosis. On an unknown date, Computerised tomogram head: no diagnosis. On an unknown date, Electromyogram: no diagnosis. On an unknown date, Lumbar puncture: no diagnosis. On an unknown date, Magnetic resonance imaging: no diagnosis.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. It was unknown whether patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. The caller was a caregiver call on behalf of her sister-in-law, reporting that 2 weeks after receiving her 1st dose given on 22-Mar-2021, she experienced numbness in 2 little toes. From then to now, it continues to rise. From her femur bone down, she had no feeling. If she lays in bed and touches one leg, she could not tell where the other leg was. She was careful when walking, could not drive and could not feel her legs. It never affected her organs but now was starting to affect her bowels and bladder. The caller waited so long to call because she was under her doctor's care and were not placing blame on the vaccine because did not know if it was the cause. The neurologist had ruled out Guillaume Barre and told her that he did not know what else to do. It was reported that they were afraid and worried that her lungs would be affected, and she would not be able to breathe. Treatment information was not provided.
Caused her body to retain water. Her tongue taste like metal. Neck pains and body pains and breast felt like it was full of milk. She couldn't sleep, mouth sores and 5 months later her neck, shoulder, head and armpits on the right side lymph nodes became swollen.
4:30pm injection --> queasy at approximately 8pm. Vomiting, diarrhea, eye discharge shivering & hot spells, abdominal pain & spasms, problems swallowing - lasted for several hours.
Information has been received from a registered nurse concerning a 12 year old patient who was vaccinated SC with 0.5 ml dose of Zostavax. (Lot # 657675/0618U) instead of Varivax. It was reported that the office was expecting an order of Varivax and an order of Zostavax and the Zostavax arrived first. According to the nurse, vaccine boxed looked similar4 and thus the Zostavax was put into children freezer instead of adult freezer. The nurse also reported that the names of both vaccines sound similar. The patient did not experience any known symptoms. Unspecified medical attention was sought. A product quality complaint was not involved. This is one of several reports received from the same source. Additional information has been requested.
Patient spouse came to our clinic on 4/29/2021 to report that on 3/18/2021 patient had a "brain bleed" and required emergency treatment. Patient died on 3/20/2021. Death certificate list cause of death as subarachnoid hemorrhage due to ruptured aneurysm
Discharge Provider: MD Primary Care Provider at Discharge: DO   Admission Date: 5/22/2022 Discharge Date: 05/27/2022   PRESENTING PROBLEM: Patient resides at Facility, brought over to ED because of nausea, vomiting and diarrhea, fever and shortness of breath. Positive for Covid. See H&P from 5/22/22 for full details   HOSPITAL COURSE: Patient was admitted to the hospitalist service with severe sepsis secondary to Covid 19 pneumonia with superimposed bacterial pneumonia and acute hypoxic respiratory failure secondary to the viral and bacterial pneumonia requiring 75% FiO2 on high flow nasal cannula. PE was ruled on by CTA. He was started on stress dose steroids for his adrenal insufficiency and IV Zosyn and Vancomycin to cover for possible bacterial pneumonia. He did require vasopressors, norepinephrine, for about 24 hours. He was initially made NPO for an SLP consult given his history of dysphagia, after eval he was placed on nectar thick liquids and dysphagia advanced diet . His oxygen demands decreased and he was off high flow nasal cannula and maintaining his blood pressures, he was transferred out of the ICU. He was on Remdesivir for which he completed a 5 day course. Antibiotic coverage was deescalated after MRSA swab resulted negative and he was on Rocephin 2g daily and completed 5 days of antibiotics. He worked with physical and occupational therapy who recommended discharge back to long term care. On day of discharge he was doing well on room air, eating and drinking okay, he will be discharged back to Facility on his dysphagia diet.
Patient received an expired vaccine; temperature excursion; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine) and PRODUCT TEMPERATURE EXCURSION ISSUE (temperature excursion) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine) and PRODUCT TEMPERATURE EXCURSION ISSUE (temperature excursion). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine) and PRODUCT TEMPERATURE EXCURSION ISSUE (temperature excursion) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  4 Moderna vials affected by temperature excursion (Lot 038C21A). Of those 4 vials, 3 of the vials were used to administer vaccinations to 9 patients over 3 days between 09-Aug-2021 to 11-Aug-2021.  Patient received an expired vaccine past 30 days in the fridge.  No treatment information was reported.
pt had non-stop screaming spell for 5 hrs-screaming started approx 4 hrs p/vax; both legs were red & swollen; no temp mom took pt to ER; told to cont giving APAP;
received 1st dose on Jan2019, wants to receive 2nd today (08Aug2022); This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on January 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.       Additional Information: GSK Receipt Date: 08-AUG-2022 Reporter's Comments: The pharmacist reported that the patient wanted to receive 2nd dose but unknown if patient received 2nd Shingrix at time of reporting. The reporter was consented to follow up. Additional supportive information: Till the time of reporting it was unknown if patient received 2nd dose of shingrix which led to incomplete course of vaccination.
Dizziness, blurry vision, abd pain, weakness, redness face/body, nauseous.
I started getting sick on Monday evening felt like swelling in my glands in my throat, back of my neck with nasal congestion.  I also had a low fever of 100.8 but sometimes it was 99.  I would say my worst day was Tuesday when I took my COVID-19 PCR test in the morning because I knew I was exposed.  I am still having symptoms now a little better each day since Tuesday,  I don't have a fever right now but I still have congestion.  I asked for Paxlovid from my Dr. and they said no I did not qualify.
Received a ZOSTAVAX vaccine on 11/22/2014 at pharmacy. I am itchy all over my body, and during day two, after vaccine injection.
Ringing in the ears, significant hearing loss, skin rashes, itchy skin, both hand numbness, joint and muscle pain, loss of energy, constant tiredness, recurring headaches, difficulty sleeping, abdominal pain, vertigo, balance problems, light headedness, short-term memory loss, reduced concentration, chills and fever immediately following vaccine.
Cough and severe congestion starting the day after vaccination. It is now 10 days after the injection and the cough (productive) has not resolved.
Priorix given IM instead SC; This case was reported by a other health professional via sales rep and described the occurrence of subcutaneous injection formulation administered by other route in a patient who received MMR (Priorix) for prophylaxis.   Co-suspect products included mmr vaccine pre-filled syringe device (Priorix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Priorix (intramuscular) and Priorix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Priorix and Priorix Pre-Filled Syringe Device, the patient experienced subcutaneous injection formulation administered by other route. On an unknown date, the outcome of the subcutaneous injection formulation administered by other route was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 23-AUG-2022 Reporter's Comments: The health care professional reported that the patient received a dose of Priorix intramuscularly instead of subcutaneously. The reporter asked what was the recommendation if Priorix was given intramuscularly instead of subcutaneously. This adverse event was being reported on behalf of a sales representative. Additional supportive information: The patient received a dose of Priorix, which led to subcutaneous injection formulation administered by other route.
ARM PAIN STARTED FEW HOURS AFTER VACCINE. COULD NOT LIFT ARM. 3 WEEKS LATER CALLED PHARMACY AND WAS ADVISED TO SEEMD. DOCTOR GAVE STEROID SHOT, X-RAY, NSAID'S AND PHYSICAL THERAPY
Vials are received in refrigerated temperatures and not frozen; Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival; Accidentally administerred refrozen vials to their patients; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Accidentally administerred refrozen vials to their patients), PRODUCT STORAGE ERROR (Vials are received in refrigerated temperatures and not frozen) and PRODUCT TEMPERATURE EXCURSION ISSUE (Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 061E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Accidentally administerred refrozen vials to their patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vials are received in refrigerated temperatures and not frozen) and PRODUCT TEMPERATURE EXCURSION ISSUE (Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Accidentally administerred refrozen vials to their patients), PRODUCT STORAGE ERROR (Vials are received in refrigerated temperatures and not frozen) and PRODUCT TEMPERATURE EXCURSION ISSUE (Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by reporter.  Vial was moved to fridge on 06-Oct-2021. Both 5.5 ml and 7.5 ml vials were received in partially thawed/liquid condition. Maximum or minimum temperature reached was 8 degree Celsius. Total duration of excursion was 4hrs.  No treatment medication was reported by reporter.   This case was linked to MOD-2022-496015 (Patient Link).
headache; fever reached (100.1 F); fever (99.4 F); feeling achy; sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE, PAIN, PAIN IN EXTREMITY, PYREXIA, and PYREXIA in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and 010A21A) for COVID-19 vaccination.     The patient's past medical history included Hypertension. Concomitant products included PROTONIX and ASPIRIN for an unknown indication.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY. On 08-Apr-2021, the patient experienced PAIN and PYREXIA. On 09-Apr-2021, the patient experienced HEADACHE and PYREXIA. At the time of the report, HEADACHE, PAIN, PAIN IN EXTREMITY, PYREXIA, and PYREXIA outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Apr-2021, Body temperature: 99.4 F. On 09-Apr-2021, Body temperature: 100.1 F.         concomitant medication include Unknown hypertension medication, Protonix, aspirin, multivitamins, Unknown anxiety medication. Treatment information was not provided Action taken with mRNA in response to the events was not applicable.  .   This case was linked to US-MODERNATX, INC-MOD-2021-072707. Sender's Comments:  US-MODERNATX, INC-MOD-2021-072707.
2nd shot for covid -19 Pfizer shot gave really bad headache for 2 days and fever for 100 F for one day next day of the shot.
Fever, chills, extreme fatigue, lightheadedness and very sore arm, but more importantly chest tightness that became increasingly worse over 48 hours. My daughter dealt with the other symptoms but her asthma became less treatable over the two days since the second shot. I finally administered the nebulizer and inhaled steroid today after all other treatments failed to relieve her symptoms. She is doing better but I will follow up with the pediatrician.
Painful, can not lift arm at shoulder, pain in back (worse when walking), fever started the night of up to 101F, chills, headache.
16 year old male give Pediarix which is for 7 year olds and younger.
nausea, chills, cellulitis on vaccine site day 8, swollen lymph nodes on armpit of vaccine site, muscle fatigue,
Client received her first dose of Pfizer vaccine and thereafter reported a metallic taste in her mouth. She was asked to wait for 30 minutes, at the end of which she reported feeling queasy. She went to the bathroom and tried to throw up, but she only had dry heaves. Vital signs: BP=119/91, Pulse=81, Respiration=18. She was asked to wait another 15 minutes to observe for progression of her symptoms, but at the end of that time she stated that she felt fine, her symptoms had improved and she was ready to leave. She was asked to call ?911? if the symptoms returned and was also asked to share her reaction to the vaccine with her Primary Care Physician, and she voiced understanding.
Side affects of the shots are awful!; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of feels awful in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced feels awful (Verbatim: Side affects of the shots are awful!). The outcome of the feels awful was not reported.   It was unknown if the reporter considered the feels awful to be related to Shingles vaccine.     It was unknown if the company considered the feels awful to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient via interactive digital media. The reporter stated that the side affects of the shots were awful. The follow-up could not be possible as no contact details were available.
Approx 5 hours after red rash on chest dry cough bright red throat spoke to pharmacist told to take Benadryl hot flashes that night itching. By the week end severe neck muscle inflammation and pounding headache saw family dr on Monday morning was given shot for inflammation and headache sent for CT of neck and head.  Had additional severe reaction to contrast dye. Lip and throat swelling large rash shaking hives.  Went to E.R. 9/29 face swelling red rash arms tingling tongue lips blood pressure 189/116.  Was given IV Benadryl.
Shot on 10-24-04, 25th swelling, 25th night 6 pm fever 100.0 increase to 102.0 middle of night fever 99.6 - 99.0 cont to 10-28-08. Right arm has hard lump size of a tennis which has shrunken; injection site warm to touch, and 10-27 started to itch.
This spontaneous report was received from a nurse refers to a patient of unknown age and gender. Medical history was not reported. The nurse informed that on 18-FEB-2014 the patient was vaccinated with M-M-R II (strength, dosage and route were not reported) lot number: J006953, expiration date: 07-JUN-2015. That may had been improperly stored since February 2014. The thermometer battery ran out in February 2014, so the refrigerator temperature was not able to be confirmed to be within recommended storage temperature since then. The highest temperature the M-M-R II could had been exposed was 70F. Also stated that was no way to determine what the exact temperature was at any given time after 01-FEB-2014 since the battery in the thermometer stopped working. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
Pt recvd vax & exp tiredness & extreme weakness less than 48 hrs later; infectious disease MD indicated the events were a coincidence & advised the pt to cont the vax series;
Very loose bowels,  causing incontinence twice, intermittently from Feb. 8 through today (13th).  Also, since Feb. 10, a mild sore throat, hurting only when I swallow. Both of these symptoms are unusual for me. Generally, I feel normal, able to eat, sleep, take walks, etc.
I had the first dose on 12/22/20.  I developed severe right shoulder pain/discomfort around 12/30.  Symptoms progressed, and I also developed frequent palpitations.  Pain and palpitations were so severe that I was not able to sleep, and went to the emergency room on 1/2/2021.  Work-up showed frequent PVCs.  Symptoms resolved over the next few days.  I am a physician.
Worsening Tinnitus, development of pulsatile tinnitus, acute loss of hearing in left ear, loss of female menstration (first vaccine)